Study finds no link between oral bisphosphonates and cancer risk

08/10/2010 | Bloomberg Businessweek

An analysis of medical data from more than 80,000 U.K. patients found that using bisphosphonates, a class of osteoporosis drugs, doesn't increase the risk of esophageal or gastric cancer. Researchers found no difference in combined incidence of the cancers between bisphosphonate users and nonusers.

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ